ReviewBreast cancer (Tokyo, Japan)2024

PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer.

Huan-Ping Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.